Insecticides (India) Limited — Updates, 10-02-2025: Press Release

Insecticides (India) Limited has reported a notable 42% year-on-year growth in Profit After Tax (PAT) for Q3FY25. The quarter demonstrated a solid financial performance with a revenue from operations of ₹357.7 crore, consistent with the previous year. Gross profit increased by 20% to ₹129.2 crore, reflecting an improvement in gross profit margin to 36.1%. EBITDA rose by 19% to ₹30.9 crore, translating to an EBITDA margin of 8.6%.

The company launched 10 new products in the first nine months, including innovative solutions like Centran and Torry Super. The strategic acquisition of Kaeros Research Private Limited aims to enhance supply chain efficiency and cost reductions. Management emphasized a strong positive outlook driven by favorable market conditions, including a promising monsoon and supportive government policies aimed at boosting farmer incomes and productivity. The focus on premium products continues to drive performance, with these now contributing 62% of B2C revenue.

Overall, the outlook remains encouraging, driven by innovation and strategic investments.